Results
|
|
141.
|
|
|
|
142.
|
Antiviral Activity, Safety, and Exposure-Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002). [electronic resource] by
- Hwang, Carey
- Schürmann, Dirk
- Sobotha, Christian
- Boffito, Marta
- Sevinsky, Heather
- Ray, Neelanjana
- Ravindran, Palanikumar
- Xiao, Hong
- Keicher, Christian
- Hüser, Andreas
- Krystal, Mark
- Dicker, Ira B
- Grasela, Dennis
- Lataillade, Max
Producer: 20180425
In:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 65
Availability: No items available.
|
|
|
143.
|
|
|
|
144.
|
Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir. [electronic resource] by
- Pineda, Juan A
- Palacios, Rosario
- Rivero, Antonio
- Abdel-kader, Laila
- Márquez, Manuel
- Cano, Pilar
- Mira, José A
- Torre-Cisneros, Julián
- Lozano, Fernando
- Santos, Jesús
Producer: 20060705
In:
The Journal of antimicrobial chemotherapy vol. 57
Availability: No items available.
|
|
|
145.
|
|
|
|
146.
|
|
|
|
147.
|
Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir. [electronic resource] by
- A M Subbaiah, Murugaiah
- Mandlekar, Sandhya
- Desikan, Sridhar
- Ramar, Thangeswaran
- Subramani, Lakshumanan
- Annadurai, Mathiazhagan
- Desai, Salil D
- Sinha, Sarmistha
- Jenkins, Susan M
- Krystal, Mark R
- Subramanian, Murali
- Sridhar, Srikanth
- Padmanabhan, Shweta
- Bhutani, Priyadeep
- Arla, Rambabu
- Singh, Shashyendra
- Sinha, Jaydeep
- Thakur, Megha
- Kadow, John F
- Meanwell, Nicholas A
Producer: 20200914
In:
Journal of medicinal chemistry vol. 62
Availability: No items available.
|
|
|
148.
|
|
|
|
149.
|
|
|
|
150.
|
Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial. [electronic resource] by
- Pérez-Valero, Ignacio
- Pasquau, Juan
- Rubio, Rafael
- Rivero, Antonio
- Santos, José
- Sanz, Jesus
- Mariño, Ana
- Crespo, Manel
- Hernández-Quero, Jose
- Iribarren, José Antonio
- Gutiérrez, Félix
- Terrón, Alberto
- Esteban, Herminia
- Pérez-Molina, José Antonio
Producer: 20191008
In:
The Journal of antimicrobial chemotherapy vol. 73
Availability: No items available.
|
|
|
151.
|
|
|
|
152.
|
|
|
|
153.
|
|
|
|
154.
|
|
|
|
155.
|
|
|
|
156.
|
|
|
|
157.
|
|
|
|
158.
|
|
|
|
159.
|
|
|
|
160.
|
|